Primary aldosteronism (PAL) is gaining recognition as an important cause of hypertension,
and attention is focusing more critically on the reliability of screening tests for PAL. However …

Primary aldosteronism (PA) is the most frequent cause of secondary arterial hypertension.
The aldosterone to renin ratio (ARR) is the gold standard for screening, but variability …

Recognition that primary aldosteronism (PAL) is a common specifically treatable form of
hypertension and that most patients are normokalemic has led to a marked increase in …

The complexity of evaluating patients for secondary treatable causes of hypertension is
underappreciated. Primary aldosteronism (PA) is the most prevalent cause of secondary …

Primary aldosteronism (PA) is a severe and often underdiagnosed form of secondary
hypertension. Determining the aldosterone to renin ratio (ARR) in hypertensive patients has …

Availability and wider application of the plasma aldosterone/renin ratio (ARR) as a
screening test for primary aldosteronism (PA) has led to the recognition that PA is the most …

Primary aldosteronism (PA) 9 is a group of adrenal disorders characterized by autonomous
production of aldosterone independent of angiotensin II (AngII) stimulation. Idiopathic …

The worldwide prevalence of primary aldosteronism (PA) among unselected patients with
hypertension is considered to be 10–15%(1, 2). However, there have always been wide …

Background Aldosterone to renin ratio (ARR) is used in screening for primary aldosteronism
(PA). However, there are only few studies on the influence of assay methods on ARR and its …

Context The plasma aldosterone concentration (PAC), renin, and aldosterone-to-renin ratio
(ARR) are used to screen for primary aldosteronism (PA). Substantial intra-individual …